갑상선 결절 환자에서 혈청 갑상선자극호르몬 수치와 고분화 갑상선암과의 연관성에 관한 분석
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김훈엽 | - |
dc.contributor.author | 정성엽 | - |
dc.contributor.author | 류우상 | - |
dc.contributor.author | 우상욱 | - |
dc.contributor.author | 손길수 | - |
dc.contributor.author | 이재복 | - |
dc.contributor.author | 배정원 | - |
dc.date.accessioned | 2021-09-08T07:15:16Z | - |
dc.date.available | 2021-09-08T07:15:16Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2010 | - |
dc.identifier.issn | 2508-8149 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/117641 | - |
dc.description.abstract | Purpose: This study investigated the effects of serum thyroid-stimulating hormone (TSH) levels in predicting malignancy-associated differentiated thyroid cancer (DTC) and benign thyroid nodules. Methods: Between January 2005 and December 2007, 346 patients underwent thyroid surgery at one hospital. Their records were retrospectively reviewed. Results: Sixty-nine percent (237 of 346) of the patients had DTC. The mean preoperative TSH level was higher than in the malignant group (5 uIU/ml vs 0.4 uIU/ml). The rate of malignancy was the 71% in patients with TSH levels >5 uIU/ml. The TSH level of DTC with metastasis of the lymph node was higher than that with non-metastasis (3.08 uIU/ml vs 2.09 uIU/ml, P<0.01)Conclusion: The likelihood of DTC increases with higher serum TSH concentration. Serum TSH level might be useful in predicting malignant nodular thyroid lesion. (Korean J Endocrine Surg 2010;10:220-223) | - |
dc.language | Korean | - |
dc.language.iso | ko | - |
dc.publisher | 대한갑상선-내분비외과학회 | - |
dc.title | 갑상선 결절 환자에서 혈청 갑상선자극호르몬 수치와 고분화 갑상선암과의 연관성에 관한 분석 | - |
dc.title.alternative | Preoperative Thyroid-stimulating Hormone Levels as a Predictor of Thyroid Carcinoma | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 김훈엽 | - |
dc.contributor.affiliatedAuthor | 배정원 | - |
dc.identifier.bibliographicCitation | The Journal of Endocrine Surgery, v.10, no.4, pp.220 - 223 | - |
dc.relation.isPartOf | The Journal of Endocrine Surgery | - |
dc.citation.title | The Journal of Endocrine Surgery | - |
dc.citation.volume | 10 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 220 | - |
dc.citation.endPage | 223 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART001515961 | - |
dc.description.journalClass | 2 | - |
dc.description.journalRegisteredClass | kci | - |
dc.description.journalRegisteredClass | other | - |
dc.subject.keywordAuthor | Thyroid carcinoma | - |
dc.subject.keywordAuthor | Thyroid stimulating hormone | - |
dc.subject.keywordAuthor | Differentiated thyroid cancer | - |
dc.subject.keywordAuthor | 갑상선암 | - |
dc.subject.keywordAuthor | 갑상선자극호르몬 | - |
dc.subject.keywordAuthor | 분화갑상선암 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.